Outlook Therapeutics Share Price (NASDAQ: OTLK)
$2.97
▲
0.29
(10.82%)
Live
Last updated on
Check the interactive Outlook Therapeutics Stock chart to analyse performance
Outlook Therapeutics stock performance
as on August 26, 2025 at 12:40 AM IST
- Today's Low:$2.80Today's High:$3.00
5.72%
Downside
Day's Volatility :6.51%
Upside
0.83%
- 52 Weeks Low:$0.8752 Weeks High:$8.32
70.71%
Downside
52 Weeks Volatility :89.54%
Upside
64.3%
Outlook Therapeutics Stock Returns
Outlook Therapeutics Inc Key Stats
Check Outlook Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Outlook Therapeutics Stock including INR - Dollar returns
The Outlook Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Outlook Therapeutics investment value today
Current value as on today
₹43,007
Returns
Returns from Outlook Therapeutics Stock
Dollar Returns*
₹4,335 (+4.33%)
Indian investors sentiment towards Outlook Therapeutics Stock
Global Institutional Holdings in Outlook Therapeutics Inc
Name
Holdings %
Schonfeld Strategic Advisors LLC
3.14%
Vanguard Group Inc
2.88%
BlackRock Inc
2.86%
Geode Capital Management, LLC
1.00%
Steward Partners Investment Advisory, LLC
0.84%
State Street Corp
0.66%
Analyst Recommendation on Outlook Therapeutics Stock
Buy
92%Buy
7%Hold
0%Sell
Based on 13 Wall street analysts offering stock ratings for Outlook Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Outlook Therapeutics Share Price Target
What analysts predicted
Upside of 189.56%
Target:
$8.60
Current:
$2.97
Outlook Therapeutics share price target is $8.60, a slight Upside of 189.56% compared to current price of $2.97 as per analysts' prediction.
Outlook Therapeutics Stock Insights
Price Movement
In the last 1 month, OTLK stock has moved up by 31.4%OTLK vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.7% return, outperforming this stock by 131.1%OTLK vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.4% return, outperforming this stock by 200.6%Price to Sales
ForOTLK every $1 of sales, investors are willing to pay $51.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.9 for every $1 of sales.
Outlook Therapeutics Technicals Summary
Sell
Neutral
Buy
Outlook Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Outlook Therapeutics Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 33.33% | 76.32% | -65.1% | -88.64% | -83.56% |
 | 5.52% | -17.35% | -50.85% | -1.12% | -3.68% |
 | 6.51% | 21.35% | 57.45% | 73.21% | 25.84% |
 | -14.26% | -17.97% | -18.13% | 40.27% | 45.64% |
 | 39.9% | 82.53% | 68.83% | 115.41% | 241.51% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| 0.59 | NA | NA | -1.83 | -0.04 | -1.31 | NA | -0.85 |
| 14.86 | 14.86 | 1.21 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.29 | -0.05 | -0.01 | NA | 34.32 |
| 28.08 | 28.08 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $119.0M | -83.56% | 0.59 | 0.0% |
| Buy | $62.5B | -3.68% | 14.86 | 31.37% |
| NA | $38.3B | 25.84% | NA | -3.89% |
| Buy | $101.3B | 45.64% | 28.08 | 31.86% |
| Buy | $59.6B | 241.51% | NA | -12.96% |
About Outlook Therapeutics Inc
Key Management of Outlook Therapeutics Inc
Important FAQs about investing in OTLK Stock from India :
What is Outlook Therapeutics share price today?
Outlook Therapeutics share price today is $2.97 as on . Outlook Therapeutics share today touched a day high of $3.00 and a low of $2.80.
What is the 52 week high and 52 week low for Outlook Therapeutics share?
Outlook Therapeutics share touched a 52 week high of $8.32 and a 52 week low of $0.87. Outlook Therapeutics stock price today i.e. is trending at $2.97, lower by 64.3% versus the 52 week high.
How to invest in Outlook Therapeutics Stock (OTLK) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Outlook Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Outlook Therapeutics Shares that will get you 0.5051 shares as per Outlook Therapeutics share price of $2.97 per share as on August 26, 2025 at 12:40 AM IST.
What is the minimum amount required to buy Outlook Therapeutics Stock (OTLK) from India?
Indian investors can start investing in Outlook Therapeutics (OTLK) shares with as little as ₹87.537 or $1 (as of August 25, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.37 in Outlook Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 25, 2025).
Based on Outlook Therapeutics share’s latest price of $2.97 as on August 26, 2025 at 12:40 AM IST, you will get 3.3670 shares of Outlook Therapeutics. Learn more about
fractional shares .
What are the returns that Outlook Therapeutics has given to Indian investors in the last 5 years?
Outlook Therapeutics stock has given -83.56% share price returns and 18.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Global X S&p 500 Tail Risk Etf
$29.08
-0.27%
- Rareview Total Return Bond Etf
$24.99
-0.24%
S&p Pharmaceuticals Spdr Etf$47.11
-0.44%
- Cambria Value And Momentum Etf
$32.05
-0.31%
- Invesco Bs 2033 Hycb Etf
$25.36
+0.0%
Ishares Msci Peru And Global Exposure Etf$53.44
+0.39%
- Ishares Intl Div Growth Etf
$79.51
-0.46%
- Lg Qraft Ai-powered Us Large Cap Core Etf
$37.81
-0.45%
- Above Food Ingredients Inc Wt Exp 062829
$0.20
+5.26%